Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics: Role of lipoxygenase and cyclooxygenase products

T. Ahmed, M. A. Wasserman, R. Muccitelli, S. Tucker, H. Gazeroglu, B. Marchette

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We investigated the role of leukotrienes and cyclooxygenase products in endotoxin-induced pulmonary vascular and airway changes. In 11 conscious sheep, measurements of pulmonary vascular resistance (PVR), lung resistance (RL), arterial P(O2), leukocyte count (WBC), and plasma thromboxane B2 (TxB2), 6-keto-PgF(1α) and PgF(2α) were obtained, before and at predetermined intervals after a 10-min infusion of E. coli endotoxin (0.3 μg/kg). On a separate occasion, 5 sheep received an infusion of the leukotriene end-organ receptor antagonist FPL-57231 (0.7 to 1 mg/kg/min), before and for as long as 4 h after endotoxin infusion; and 6 sheep received a single injection of the cyclooxygenase inhibitor indomethacin (2 mg/kg) 1 h before endotoxin infusion. Endotoxin caused a biphasic response with an increase in mean PVR and RL to 441 and 353% of baseline, respectively, during the early phase (0 to 1 h), and lesser increases to 168 and 195% of baseline during the late phase (1.5 to 4 h). These changes were associated with mild hypoxemia, marked leukopenia, and marked increases in plasma TxB2, 6-keto-PgF(1α) and PgF(2α). The FPL-57231 completely blocked the endotoxin-induced changed in PVR, RL, and Pa(O2) during both phases without preventing the increases in TxB2; however, it partly attenuated the increases in 6-keto-PgF(1α) and enhanced the generation of PgF(2α). Indomethacin, which blocked the endotoxin-induced increases in TxB2, 6-keto-PgF(1α) PgF(2α), and RL, only partly blocked the increase in PVR during the early phase, followed by an exaggerated increase in PVR during the late phase. Both FPL-57231 and indomethacin failed to prevent the endotoxin-induced decrease in WBC count. In another group of 5 sheep, a 10-min infusion of FPL-57231, 4 h after endotoxin, reversed the Phase II increase in PVR. These data indicate that leukotrienes may play an important role in endotoxin-induced changes in pulmonary hemodynamics and airway mechanics. The increase in RL and initial changes in PVR may be mediated by leukotrienes and cyclooxygenase products, whereas the subsequent changes in PVR appear to be predominantly mediated by leukotrienes.

Original languageEnglish
Pages (from-to)1149-1157
Number of pages9
JournalAmerican Review of Respiratory Disease
Volume134
Issue number6
StatePublished - Dec 1 1986
Externally publishedYes

Fingerprint

Respiratory Mechanics
Lipoxygenase
Prostaglandin-Endoperoxide Synthases
Endotoxins
Vascular Resistance
Hemodynamics
Lung
Leukotrienes
Thromboxane B2
Sheep
Indomethacin
Cyclooxygenase 2 Inhibitors
Leukopenia
Mechanics
Leukocyte Count
Blood Vessels
Escherichia coli

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ahmed, T., Wasserman, M. A., Muccitelli, R., Tucker, S., Gazeroglu, H., & Marchette, B. (1986). Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics: Role of lipoxygenase and cyclooxygenase products. American Review of Respiratory Disease, 134(6), 1149-1157.

Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics : Role of lipoxygenase and cyclooxygenase products. / Ahmed, T.; Wasserman, M. A.; Muccitelli, R.; Tucker, S.; Gazeroglu, H.; Marchette, B.

In: American Review of Respiratory Disease, Vol. 134, No. 6, 01.12.1986, p. 1149-1157.

Research output: Contribution to journalArticle

Ahmed, T, Wasserman, MA, Muccitelli, R, Tucker, S, Gazeroglu, H & Marchette, B 1986, 'Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics: Role of lipoxygenase and cyclooxygenase products', American Review of Respiratory Disease, vol. 134, no. 6, pp. 1149-1157.
Ahmed, T. ; Wasserman, M. A. ; Muccitelli, R. ; Tucker, S. ; Gazeroglu, H. ; Marchette, B. / Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics : Role of lipoxygenase and cyclooxygenase products. In: American Review of Respiratory Disease. 1986 ; Vol. 134, No. 6. pp. 1149-1157.
@article{d066692e93be4be884027c8edf8380b2,
title = "Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics: Role of lipoxygenase and cyclooxygenase products",
abstract = "We investigated the role of leukotrienes and cyclooxygenase products in endotoxin-induced pulmonary vascular and airway changes. In 11 conscious sheep, measurements of pulmonary vascular resistance (PVR), lung resistance (RL), arterial P(O2), leukocyte count (WBC), and plasma thromboxane B2 (TxB2), 6-keto-PgF(1α) and PgF(2α) were obtained, before and at predetermined intervals after a 10-min infusion of E. coli endotoxin (0.3 μg/kg). On a separate occasion, 5 sheep received an infusion of the leukotriene end-organ receptor antagonist FPL-57231 (0.7 to 1 mg/kg/min), before and for as long as 4 h after endotoxin infusion; and 6 sheep received a single injection of the cyclooxygenase inhibitor indomethacin (2 mg/kg) 1 h before endotoxin infusion. Endotoxin caused a biphasic response with an increase in mean PVR and RL to 441 and 353{\%} of baseline, respectively, during the early phase (0 to 1 h), and lesser increases to 168 and 195{\%} of baseline during the late phase (1.5 to 4 h). These changes were associated with mild hypoxemia, marked leukopenia, and marked increases in plasma TxB2, 6-keto-PgF(1α) and PgF(2α). The FPL-57231 completely blocked the endotoxin-induced changed in PVR, RL, and Pa(O2) during both phases without preventing the increases in TxB2; however, it partly attenuated the increases in 6-keto-PgF(1α) and enhanced the generation of PgF(2α). Indomethacin, which blocked the endotoxin-induced increases in TxB2, 6-keto-PgF(1α) PgF(2α), and RL, only partly blocked the increase in PVR during the early phase, followed by an exaggerated increase in PVR during the late phase. Both FPL-57231 and indomethacin failed to prevent the endotoxin-induced decrease in WBC count. In another group of 5 sheep, a 10-min infusion of FPL-57231, 4 h after endotoxin, reversed the Phase II increase in PVR. These data indicate that leukotrienes may play an important role in endotoxin-induced changes in pulmonary hemodynamics and airway mechanics. The increase in RL and initial changes in PVR may be mediated by leukotrienes and cyclooxygenase products, whereas the subsequent changes in PVR appear to be predominantly mediated by leukotrienes.",
author = "T. Ahmed and Wasserman, {M. A.} and R. Muccitelli and S. Tucker and H. Gazeroglu and B. Marchette",
year = "1986",
month = "12",
day = "1",
language = "English",
volume = "134",
pages = "1149--1157",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics

T2 - Role of lipoxygenase and cyclooxygenase products

AU - Ahmed, T.

AU - Wasserman, M. A.

AU - Muccitelli, R.

AU - Tucker, S.

AU - Gazeroglu, H.

AU - Marchette, B.

PY - 1986/12/1

Y1 - 1986/12/1

N2 - We investigated the role of leukotrienes and cyclooxygenase products in endotoxin-induced pulmonary vascular and airway changes. In 11 conscious sheep, measurements of pulmonary vascular resistance (PVR), lung resistance (RL), arterial P(O2), leukocyte count (WBC), and plasma thromboxane B2 (TxB2), 6-keto-PgF(1α) and PgF(2α) were obtained, before and at predetermined intervals after a 10-min infusion of E. coli endotoxin (0.3 μg/kg). On a separate occasion, 5 sheep received an infusion of the leukotriene end-organ receptor antagonist FPL-57231 (0.7 to 1 mg/kg/min), before and for as long as 4 h after endotoxin infusion; and 6 sheep received a single injection of the cyclooxygenase inhibitor indomethacin (2 mg/kg) 1 h before endotoxin infusion. Endotoxin caused a biphasic response with an increase in mean PVR and RL to 441 and 353% of baseline, respectively, during the early phase (0 to 1 h), and lesser increases to 168 and 195% of baseline during the late phase (1.5 to 4 h). These changes were associated with mild hypoxemia, marked leukopenia, and marked increases in plasma TxB2, 6-keto-PgF(1α) and PgF(2α). The FPL-57231 completely blocked the endotoxin-induced changed in PVR, RL, and Pa(O2) during both phases without preventing the increases in TxB2; however, it partly attenuated the increases in 6-keto-PgF(1α) and enhanced the generation of PgF(2α). Indomethacin, which blocked the endotoxin-induced increases in TxB2, 6-keto-PgF(1α) PgF(2α), and RL, only partly blocked the increase in PVR during the early phase, followed by an exaggerated increase in PVR during the late phase. Both FPL-57231 and indomethacin failed to prevent the endotoxin-induced decrease in WBC count. In another group of 5 sheep, a 10-min infusion of FPL-57231, 4 h after endotoxin, reversed the Phase II increase in PVR. These data indicate that leukotrienes may play an important role in endotoxin-induced changes in pulmonary hemodynamics and airway mechanics. The increase in RL and initial changes in PVR may be mediated by leukotrienes and cyclooxygenase products, whereas the subsequent changes in PVR appear to be predominantly mediated by leukotrienes.

AB - We investigated the role of leukotrienes and cyclooxygenase products in endotoxin-induced pulmonary vascular and airway changes. In 11 conscious sheep, measurements of pulmonary vascular resistance (PVR), lung resistance (RL), arterial P(O2), leukocyte count (WBC), and plasma thromboxane B2 (TxB2), 6-keto-PgF(1α) and PgF(2α) were obtained, before and at predetermined intervals after a 10-min infusion of E. coli endotoxin (0.3 μg/kg). On a separate occasion, 5 sheep received an infusion of the leukotriene end-organ receptor antagonist FPL-57231 (0.7 to 1 mg/kg/min), before and for as long as 4 h after endotoxin infusion; and 6 sheep received a single injection of the cyclooxygenase inhibitor indomethacin (2 mg/kg) 1 h before endotoxin infusion. Endotoxin caused a biphasic response with an increase in mean PVR and RL to 441 and 353% of baseline, respectively, during the early phase (0 to 1 h), and lesser increases to 168 and 195% of baseline during the late phase (1.5 to 4 h). These changes were associated with mild hypoxemia, marked leukopenia, and marked increases in plasma TxB2, 6-keto-PgF(1α) and PgF(2α). The FPL-57231 completely blocked the endotoxin-induced changed in PVR, RL, and Pa(O2) during both phases without preventing the increases in TxB2; however, it partly attenuated the increases in 6-keto-PgF(1α) and enhanced the generation of PgF(2α). Indomethacin, which blocked the endotoxin-induced increases in TxB2, 6-keto-PgF(1α) PgF(2α), and RL, only partly blocked the increase in PVR during the early phase, followed by an exaggerated increase in PVR during the late phase. Both FPL-57231 and indomethacin failed to prevent the endotoxin-induced decrease in WBC count. In another group of 5 sheep, a 10-min infusion of FPL-57231, 4 h after endotoxin, reversed the Phase II increase in PVR. These data indicate that leukotrienes may play an important role in endotoxin-induced changes in pulmonary hemodynamics and airway mechanics. The increase in RL and initial changes in PVR may be mediated by leukotrienes and cyclooxygenase products, whereas the subsequent changes in PVR appear to be predominantly mediated by leukotrienes.

UR - http://www.scopus.com/inward/record.url?scp=0023001552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023001552&partnerID=8YFLogxK

M3 - Article

C2 - 3098146

AN - SCOPUS:0023001552

VL - 134

SP - 1149

EP - 1157

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -